Northeast Pharmaceutical Group Co Ltd (000597) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, Northeast Pharmaceutical Group Co Ltd (000597) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥274.09 Million ≈ $40.11 Million USD) by net assets (CN¥5.60 Billion ≈ $819.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000597 market cap for the company's overall valuation and market capitalisation.

Northeast Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Northeast Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Northeast Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Northeast Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore Northeast Pharmaceutical Group Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
O-Bank Co Ltd TW:2897	0.002x
Redcare Pharmacy NV F:RDC	-0.039x
Primax Electronics Ltd TW:4915	0.053x
Shenyang Toly Bread Co Ltd SHG:603866	0.043x
Changjiang & Jinggong Steel Building Group Co Ltd SHG:600496	0.037x
Beijing Asiacom Information Technology Co.Ltd SHE:301085	N/A
Quantum Corporation NASDAQ:QMCO	-0.034x
Retail Estates - Sicafi BR:RET	0.026x

Annual Cash Flow Conversion Efficiency for Northeast Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Northeast Pharmaceutical Group Co Ltd from 1998 to 2025. View 000597 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.67 Billion ≈ $829.59 Million	CN¥1.11 Billion ≈ $161.90 Million	0.195x	+43.25%
2024-12-31	CN¥5.57 Billion ≈ $815.01 Million	CN¥758.76 Million ≈ $111.03 Million	0.136x	+19.78%
2023-12-31	CN¥5.16 Billion ≈ $754.89 Million	CN¥586.75 Million ≈ $85.86 Million	0.114x	-51.64%
2022-12-31	CN¥4.71 Billion ≈ $689.70 Million	CN¥1.11 Billion ≈ $162.22 Million	0.235x	+35.17%
2021-12-31	CN¥4.29 Billion ≈ $627.80 Million	CN¥746.51 Million ≈ $109.24 Million	0.174x	+25.63%
2020-12-31	CN¥4.12 Billion ≈ $603.21 Million	CN¥570.92 Million ≈ $83.54 Million	0.138x	+53.89%
2019-12-31	CN¥3.92 Billion ≈ $573.30 Million	CN¥352.60 Million ≈ $51.60 Million	0.090x	+13.42%
2018-12-31	CN¥3.59 Billion ≈ $525.75 Million	CN¥285.09 Million ≈ $41.72 Million	0.079x	+167.13%
2017-12-31	CN¥2.55 Billion ≈ $372.85 Million	CN¥-301.20 Million ≈ $-44.07 Million	-0.118x	-174.83%
2016-12-31	CN¥2.43 Billion ≈ $356.17 Million	CN¥384.51 Million ≈ $56.27 Million	0.158x	+280.44%
2015-12-31	CN¥2.40 Billion ≈ $351.34 Million	CN¥99.70 Million ≈ $14.59 Million	0.042x	+144.00%
2014-12-31	CN¥2.76 Billion ≈ $404.05 Million	CN¥46.99 Million ≈ $6.88 Million	0.017x	+110.22%
2013-12-31	CN¥1.60 Billion ≈ $233.99 Million	CN¥-266.38 Million ≈ $-38.98 Million	-0.167x	-438.70%
2012-12-31	CN¥1.75 Billion ≈ $256.13 Million	CN¥86.09 Million ≈ $12.60 Million	0.049x	+136.74%
2011-12-31	CN¥1.74 Billion ≈ $255.03 Million	CN¥-233.32 Million ≈ $-34.14 Million	-0.134x	-208.03%
2010-12-31	CN¥2.07 Billion ≈ $302.24 Million	CN¥255.96 Million ≈ $37.46 Million	0.124x	-58.68%
2009-12-31	CN¥2.05 Billion ≈ $300.50 Million	CN¥615.91 Million ≈ $90.13 Million	0.300x	-33.40%
2008-12-31	CN¥1.57 Billion ≈ $230.40 Million	CN¥709.03 Million ≈ $103.75 Million	0.450x	+101.66%
2007-12-31	CN¥889.22 Million ≈ $130.12 Million	CN¥198.56 Million ≈ $29.06 Million	0.223x	+295.39%
2006-12-31	CN¥927.49 Million ≈ $135.72 Million	CN¥-106.00 Million ≈ $-15.51 Million	-0.114x	-192.34%
2005-12-31	CN¥900.07 Million ≈ $131.71 Million	CN¥111.40 Million ≈ $16.30 Million	0.124x	-48.16%
2004-12-31	CN¥884.02 Million ≈ $129.36 Million	CN¥211.06 Million ≈ $30.88 Million	0.239x	-9.70%
2003-12-31	CN¥870.26 Million ≈ $127.35 Million	CN¥230.08 Million ≈ $33.67 Million	0.264x	+46.67%
2002-12-31	CN¥873.28 Million ≈ $127.79 Million	CN¥157.41 Million ≈ $23.03 Million	0.180x	+101.95%
2001-12-31	CN¥883.36 Million ≈ $129.26 Million	CN¥78.84 Million ≈ $11.54 Million	0.089x	+123.72%
2000-12-31	CN¥905.53 Million ≈ $132.51 Million	CN¥36.13 Million ≈ $5.29 Million	0.040x	-36.48%
1999-12-31	CN¥869.73 Million ≈ $127.27 Million	CN¥54.62 Million ≈ $7.99 Million	0.063x	+926.23%
1998-12-31	CN¥999.14 Million ≈ $146.21 Million	CN¥-7.59 Million ≈ $-1.11 Million	-0.008x	--

About Northeast Pharmaceutical Group Co Ltd

SHE:000597 China Drug Manufacturers - Specialty & Generic

Market Cap

$973.03 Million

CN¥6.65 Billion CNY

Market Cap Rank

#9088 Global

#2246 in China

Share Price

CN¥4.66

Change (1 day)

-0.21%

52-Week Range

CN¥4.20 - CN¥5.86

All Time High

CN¥133.00